高级检索
当前位置: 首页 > 详情页

TNFRSF1B+676 T>G polymorphism predicts survival of non-Small cell lung cancer patients treated with chemoradiotherapy

文献详情

资源类型:
WOS体系:

收录情况: ◇ SCIE

单位: [1]Univ Texas MD Anderson Canc Ctr, Dept Epidemiol, Houston, TX 77030 USA [2]Univ Texas MD Anderson Canc Ctr, Dept Radiat Oncol, Houston, TX 77030 USA [3]Huazhong Univ Sci & Technol, Tongji Hosp, Tongji Med Coll, Dept Oncol, Wuhan 430030, Peoples R China
出处:
ISSN:

关键词: TNF-alpha?a TNFRSF1B polymorphism non-small cell lung cancer survival

摘要:
Background: The dysregulation of gene expression in the TNF-TNFR superfamily has been involved in various human cancers including non-small cell lung cancer (NSCLC). Furthermore, functional polymorphisms in TNF-alpha and TNFRSF1B genes that alter gene expression are likely to be associated with risk and clinical outcomes of cancers. However, few reported studies have investigated the association between potentially functional SNPs in both TNF-alpha and TNFRSF1B and prognosis of NSCLC patients treated with chemoradiotherapy. Methods: We genotyped five potentially functional polymorphisms of TNF-alpha and TNFRSF1B genes [TNF-alpha -308 G>A (rs1800629) and -1031 T>C (rs1799964); TNFRSF1B +676 T>G (rs1061622), -1709A>T(rs652625) and +1663A>G (rs1061624)] in 225 NSCLC patients treated with chemoradiotherapy or radiotherapy alone. Kaplan-Meier survival analysis, log-rank tests and Cox proportional hazard models were used to evaluate associations between these variants and NSCLC overall survival (OS). Results: We found that the TNFRSF1B +676 GG genotype was associated with a significantly better OS of NSCLC (GG vs. TT: adjusted HR = 0.38, 95% CI = 0.15-0.94; GG vs. GT/TT: adjusted HR = 0.35, 95% CI = 0.14-0.88). Further stepwise multivariate Cox regression analysis showed that the TNFRSF1B +676 GG was an independent prognosis predictor in this NSCLC cohort (GG vs. GT/TT: HR = 0.35, 95% CI = 0.14-0.85), in the presence of node status (N(2-3) vs. N(0-1): HR = 1.60, 95% CI = 1.09-2.35) and tumor stage (T(3-4) vs. T(0-2): HR = 1.48, 95% CI = 1.08-2.03). Conclusions: Although the exact biological function for this SNP remains to be explored, our findings suggest a possible role of TNFRSF1B +676 T>G (rs1061622) in the prognosis of NSCLC. Further large and functional studies are needed to confirm our findings.

基金:
语种:
被引次数:
WOS:
PubmedID:
中科院(CAS)分区:
出版当年[2010]版:
大类 | 3 区 医学
小类 | 3 区 肿瘤学
最新[2025]版:
大类 | 3 区 医学
小类 | 3 区 肿瘤学
JCR分区:
出版当年[2009]版:
Q2 ONCOLOGY
最新[2023]版:
Q2 ONCOLOGY

影响因子: 最新[2023版] 最新五年平均 出版当年[2009版] 出版当年五年平均 出版前一年[2008版] 出版后一年[2010版]

第一作者:
第一作者单位: [1]Univ Texas MD Anderson Canc Ctr, Dept Epidemiol, Houston, TX 77030 USA
通讯作者:
通讯机构: [2]Univ Texas MD Anderson Canc Ctr, Dept Radiat Oncol, Houston, TX 77030 USA [*1]Univ Texas MD Anderson Canc Ctr, Dept Epidemiol, 1515 Holcombe Blvd, Houston, TX 77030 USA
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:589 今日访问量:0 总访问量:441 更新日期:2025-06-01 建议使用谷歌、火狐浏览器 常见问题

版权所有:重庆聚合科技有限公司 渝ICP备12007440号-3 地址:重庆市两江新区泰山大道西段8号坤恩国际商务中心16层(401121)